The dual ability of CCL5 to provide carcinogenesis or antitumor adjuvanticity depending on the tumor environment appears to be justified by the type of cancer, CCR5 expression and localization of CCL5 expression [78,79]. This evidence concerns the gene CCL5 and neoplasm.